Fig. 3

(a) Distribution of linezolid Cmin in the two groups. (b) More patients with Cmin < 2 mg/L in the TBI group and more patients with Cmin >7 mg/L in the non-TBI group. *Represents a statistically significant difference.

(a) Distribution of linezolid Cmin in the two groups. (b) More patients with Cmin < 2 mg/L in the TBI group and more patients with Cmin >7 mg/L in the non-TBI group. *Represents a statistically significant difference.